Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Cherise Cortese is active.

Publication


Featured researches published by Cherise Cortese.


The American Journal of Gastroenterology | 2003

Orlistat in the Treatment of NASH: A Case Series

Stephen A. Harrison; Sanjay Ramrakhiani; Elizabeth M. Brunt; Maan A Anbari; Cherise Cortese; Bruce R. Bacon

Nonalcoholic steatohepatitis is now recognized as a common chronic liver disorder. Up to 16% of affected patients may progress to cirrhosis. The incidence and prevalence of this disease are noted to be increasing, in parallel with the nationwide increase in obesity and diabetes. Treatment options for these patients remain quite limited, however. Weight reduction has been advocated, but there are little data to support this practice, as most patients are unable to comply with the proper dietary modifications. We report three obese patients with biopsy-proven nonalcoholic steatohepatitis treated for 6–12 months with a weight reduction medication, orlistat, who lost between 22–42 lb, and had significant clinical and histopathological improvement on follow-up.


Transplant International | 2005

C4d peritubular capillary staining in chronic allograft nephropathy and transplant glomerulopathy: an uncommon finding

Ziyad Al Aly; Praveen Yalamanchili; Cherise Cortese; Luis Salinas-Madrigal; Bahar Bastani

The true incidence of positive C4d staining in the peritubular capillaries of biopsies with chronic allograft nephropathy (CAN) and transplant glomerulopathy (TGP) remains controversial. We retrospectively reviewed all transplant biopsies performed at Saint Louis University Hospital between June 2002 and May 2004. We examined the incidence of positive C4d staining in the peritubular capillaries of biopsy specimens with pure CAN with or without features of TGP. We identified 54 biopsies in 43 patients showing CAN. The average age was 46 ± 13 years. The average creatinine at the time of biopsy was 308 ± 211 μmol/l (3.5 ± 2.4 mg/dl). Twenty (37%) biopsies exhibited features consistent with TGP. Only two biopsies had positive C4d staining in the peritubular capillaries. The C4d positive biopsies were from two different patients; one patient had donor specific antibodies (DSA) against HLA class 1 at the time of biopsy and the other patient had no detectable DSA. None of the TGP biopsies showed peritubular C4d staining. C4d staining of the peritubular capillaries appears to be rare in patients with pure CAN with and without TGP features.


Journal of Interferon and Cytokine Research | 2002

Hepatic Iron Concentration Does Not Influence Response to Therapy with Interferon Plus Ribavirin in Chronic HCV Infection

Stephen Pianko; John G. McHutchison; Stuart C. Gordon; Shanon Heaton; Zachary D. Goodman; Keyur Patel; Cherise Cortese; Elizabeth M. Brunt; Bruce R. Bacon; Lawrence M. Blatt

In patients with chronic hepatitis C, prior studies have suggested that increased hepatic iron concentration (HIC) is predictive of a poor response to interferon (IFN) monotherapy. The aim of this study was to assess the importance of HIC on the virologic response to therapy with IFN alone or when combined with ribavirin. Records of 91 patients were reviewed for inclusion in this study. Fifty-one received IFN alone, and 40 received IFN plus ribavirin. HIC and serum iron studies, alanine aminotransferase (ALT) values, hepatitis C virus (HCV) genotype, and HCV RNA were determined prior to therapy. Sustained response was defined as the absence of HCV RNA 6 months after the end of therapy. In the IFN monotherapy group, mean HIC was higher for nonresponders (803 + 89 microg/g, range 130-2808 microg/g) compared with sustained responders (241 + 54 micro g/g, range 187-295 microg/g) (p < 0.01). In contrast, in the combination therapy group, the mean HIC was similar for both groups (533 + 86 microg/g, range 79-1338 microg/g in the nonresponders, and 662 + 95 microg/g, range 94-2031 microg/g, in the sustained responders). No difference between transferrin saturation and serum ferritin level was observed in sustained responder or nonresponder patients treated with IFN plus ribavirin. IFN monotherapy nonresponder patients tended to have a higher HIC. With IFN plus ribavirin, the sustained virologic response rate was not affected by the HIC.


Clinical Gastroenterology and Hepatology | 2008

Immunostaining as an Adjunct to Cytology for Diagnosis of Pancreatic Adenocarcinoma

Banke Agarwal; Olivia J. Ludwig; Brian T. Collins; Cherise Cortese

BACKGROUND & AIMS Serial analysis of gene expression has helped identify several proteins that are expressed differentially in pancreatic cancer and are highly sensitive and specific for pancreatic adenocarcinoma. We evaluated if the diagnostic accuracy of pancreatic cancer from endoscopic ultrasound (EUS)-fine-needle aspiration (FNA) can be improved by combined evaluation of cytology and immunostaining with these markers. METHODS This study involved the use of archived specimens from patients treated at Saint Louis University Hospital from 2002 to 2006. We identified 5 protein markers that appeared most promising from published literature. We sequentially evaluated immunostaining with these markers in (1) surgical resection specimens, (2) cell blocks from EUS-FNA, and (3) direct smears of EUS-FN aspirates. Finally, we performed a combined evaluation of cytology and immunostaining in direct smears that were difficult to interpret and required a second consultative cytologic opinion. RESULTS In resection specimens, the majority of pancreatic adenocarcinomas expressed all 5 markers but fascin, maspin, and carcinoembryonic antigen-related cell adhesion molecule 6 also were expressed abnormally in normal pancreata and in chronic pancreatitis. Further evaluation therefore was limited to the other 2 markers: mesothelin and 14-3-3sigma. It was feasible and useful to perform immunostaining in cell blocks and direct smear for diagnosing pancreatic cancer. In cases requiring a second cytologic consultation, a combined evaluation of cytologic morphology and immunostaining had 90% accuracy for a pancreatic adenocarcinoma diagnosis. CONCLUSIONS In conclusion, immunostaining with newer protein markers is feasible in EUS-FNA specimens and can assist cytopathologists in diagnosing pancreatic cancer. Among the currently available protein immunomarkers, a combination of mesothelin and 14-3-3sigma seems most promising, but needs to be validated in prospective studies before routine clinical use.


Transplant International | 2008

Renal allograft biopsies in the era of C4d staining: the need for change in the Banff classification system

Ziyad Al-Aly; Venkata Reddivari; Abdul Moiz; Geetha Balasubramanian; Cherise Cortese; Luis Salinas-Madrigal; Bahar Bastani

C4d immunostaining in the peritubular capillaries (PTC) is a marker of antibody‐mediated rejection (AMR). We evaluated the histopathologic diagnoses of 388 renal transplant biopsies since the implementation of routine C4d immunostaining at our center. Of these, 155 (40%) biopsies had evidence of acute cellular rejection (ACR), out of which 119 (77%) had pure ACR, 31 (20%) had ACR with concomitant features of AMR, and five (3%) had ACR with focal C4d staining. Sixty‐four (16%) biopsies exhibited features of AMR [33 (52%) pure AMR, and 31(48%) concomitant AMR and ACR]. One hundred and fifty‐five (40%) biopsies had features of interstitial fibrosis and tubular atrophy (IFTA). Of these, 20 (13%) had concomitant AMR [13 (8.5%) had pure AMR and seven (4.5%) had concomitant ACR and AMR]. Creatinine at the time of biopsy was higher in patients with mixed ACR and AMR and the clinical behavior of mixed lesions is more aggressive over time. Despite having a lower serum creatinine at the time of biopsy, patients with IFTA experienced gradual decline in graft function over time. The pathologic findings in renal allograft biopsies are often mixed and mixed lesions appear to have more aggressive clinical behavior. These findings suggest the need for change in the Banff classification system to better capture the complexity of renal allograft pathologies.


Acta Cytologica | 2009

Fine Needle Aspiration Biopsy of Monophasic Spindle Synovial Sarcoma of Lung with Fluorescence in Situ Hybridization Identification of t(x;18) Translocation : A Case Report

Brian T. Collins; Christine G. Janney; Menchu Ong; Cherise Cortese

BACKGROUND Primary monophasic spindle synovial sarcoma can occur in areas with no apparent relation to synovial structures. The diagnosis can be challenging because of the ability to mimic other spindle cell neoplasms. Within the lung, these neoplasms are rare and cytologic descriptions are limited. CASE A 58-year-old woman was diagnosed with colonic adenocarcinoma; chest computed tomography (CT) revealed a 5-cm solitary pulmonary mass, and CT-guided fine needle aspiration was performed. Aspirate smears were cellular, with large, loosely cohesive complex tissue fragments that showed dense spindled cells with numerous single stripped spindle cells. Spindle cells were bland and monomorphic, with minimal cellular variation. There was no anaplasia or specific mesenchymal differentiation. Immunohistochemical stains on the cell block were positive for vimentin and bcl-2. A diagnosis of spindle cell neoplasm was rendered; it was believed to be a second neoplasm unrelated to the colonic adenocarcinoma. The main diagnostic consideration was synovial sarcoma. On resection, the neoplasm demonstrated t(x:1 8) chromosomal translocation by fluorescence in situ hybridization. CONCLUSION In a spindled cell neoplasm arising as a single peripheral pulmonary nodule, monophacir spindle synorvial sarcoma should be considered in the differential diagnosis; detection of the t(x;18) chromosomal translocation can confirm the diagnosis.


American Journal of Kidney Diseases | 2005

Nephrogenic fibrosing dermopathy/nephrogenic systemic fibrosis: report of a new case with literature review.

Sumanth R. Daram; Cherise Cortese; Bahar Bastani


Journal of Clinical Oncology | 2007

Spontaneous Rupture of the Spleen in the Presentation of Acute Myeloid Leukemia

Alan Tan; Mohammadbagher Ziari; Huda Salman; Wilman Ortega; Cherise Cortese


Journal of Heart and Lung Transplantation | 2006

Fulminant Acute Cellular Rejection With Negative Findings on Endomyocardial Biopsy

Rajeshkumar Bhalodolia; Cherise Cortese; Michael A. Graham; Paul J. Hauptman


Archives of Pathology & Laboratory Medicine | 2009

Pathologic Quiz Case: A 58-Year-Old Man With a Pancreatic Mass

Csaba Galambos; Cherise Cortese; Christine G. Janney

Collaboration


Dive into the Cherise Cortese's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Elizabeth M. Brunt

Washington University in St. Louis

View shared research outputs
Top Co-Authors

Avatar

Abdul Moiz

Saint Louis University

View shared research outputs
Researchain Logo
Decentralizing Knowledge